---
title: "Smith & Nephew plc (SNN.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SNN.US.md"
symbol: "SNN.US"
name: "Smith & Nephew plc"
industry: "Health Care Equipment"
datetime: "2026-04-16T19:54:22.754Z"
locales:
  - [en](https://longbridge.com/en/quote/SNN.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNN.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNN.US.md)
---

# Smith & Nephew plc (SNN.US)

## Company Overview

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.smith-nephew.com](https://www.smith-nephew.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-16T04:30:17.000Z

**Overall: B (0.38)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 12 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.09% |  |
| Net Profit YoY | 51.70% |  |
| P/B Ratio | 2.76 |  |
| Dividend Ratio | 2.20% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 14611457463.78 |  |
| Revenue | 6164000000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 11.84% | B |
| Profit Margin | 10.14% | B |
| Gross Margin | 68.25% | A |
| Revenue YoY | 6.09% | C |
| Net Profit YoY | 51.70% | B |
| Total Assets YoY | 0.99% | C |
| Net Assets YoY | 0.46% | C |
| Cash Flow Margin | 205.60% | B |
| OCF YoY | 6.09% | C |
| Turnover | 0.59 | B |
| Gearing Ratio | 49.42% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Smith & Nephew plc",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "6.09%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "51.70%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.76",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.20%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "14611457463.78",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "6164000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "11.84%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "10.14%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "68.25%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "6.09%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "51.70%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.99%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.46%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "205.60%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "6.09%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.59",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "49.42%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 23.38 | 13/183 | 32.12 | 30.43 | 28.25 |
| PB | 2.76 | 69/183 | 2.80 | 2.57 | 2.48 |
| PS (TTM) | 2.37 | 60/183 | 2.60 | 2.35 | 2.22 |
| Dividend Yield | 2.20% | 8/183 | 2.40% | 2.22% | 2.01% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Abbott Laboratories (ABT.US) | B | C | C | C | B | B |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | B | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | B | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-16T04:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 20% |
| Hold | 4 | 80% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 33.85 |
| Highest Target | 39.00 |
| Lowest Target | 34.91 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SNN.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SNN.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SNN.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SNN.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**